Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Case Reports
. 2025 Jul 12:39:102390.
doi: 10.1016/j.ajoc.2025.102390. eCollection 2025 Sep.

Biopsy-proven sarcoidosis lesion of the levator palpebrae superioris causing myogenic blepharoptosis

Affiliations
Case Reports

Biopsy-proven sarcoidosis lesion of the levator palpebrae superioris causing myogenic blepharoptosis

Kim A Firn et al. Am J Ophthalmol Case Rep. .

Abstract

Purpose: We describe a case of myogenic blepharoptosis due to sarcoidosis directly involving the levator palpebrae superioris, confirmed with biopsy.

Observations: A 43-year-old male with hypertension and hyperlipidemia presented with four months of progressive right blepharoptosis and two months of dry cough. Workup revealed elevated serum muramidase, hilar adenopathy, and bilateral lacrimal gland and right levator MRI enhancement. Both lacrimal gland biopsy and later levator biopsy were consistent with sarcoidosis.

Conclusions and importance: Most sarcoidosis-related blepharoptosis is secondary to Horner syndrome or mass effect from lacrimal gland enlargement. On literature review, we did not identify prior biopsy-confirmed direct involvement of the levator as a cause of sarcoidosis-related blepharoptosis. No cases were identified with isolated levator enhancement without involvement of other extraocular muscles. In this case, both the lacrimal gland and levator biopsies were consistent with sarcoidosis. It is possible that prior reports of sarcoidosis-related blepharoptosis secondary to lacrimal gland enlargement with positive biopsy were in fact due to direct co-involvement of the levator. The exact mechanism of sarcoidosis-related blepharoptosis impacts the proposed surgical intervention if indicated after failed medical therapy, and direct levator involvement should be considered prior to surgical planning.

Keywords: Blepharoptosis; Orbital inflammation; Orbital sarcoidosis; Ptosis; Sarcoidosis.

PubMed Disclaimer

Conflict of interest statement

The authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.

Figures

Fig. 1
Fig. 1
External photographs. There was minimal right levator function with an MRD1 of 0 mm at presentation (top), which worsened six months later to complete blepharoptosis (second from the top). Postoperative day 1 after the first frontalis sling procedure is shown in the photo second from the bottom. The bottom photo shows the postoperative day 1 photo after sling revision.
Fig. 2
Fig. 2
Orbital MRI. Subtle enhancement of the right levator is indicated by the arrow in the top panel. Bilateral lacrimal glands show enlargement with asymmetric enhancement as indicated by the arrows in the panel second from the top.
Fig. 3
Fig. 3
Right lacrimal gland and orbital soft tissue biopsies. The arrow indicates granulomatous inflammation and multinucleated giant cells (left). Arrows indicate multinucleated giant cells in levator, connective tissue (top left of right images), orbital septum adipose tissue (top right of right images), orbital fat (middle left and right of right images), and preaponeurotic fat (lower right of right images). The lower left panel of the right images highlights a large perivascular inflammatory cuff in levator and orbital fat.

References

    1. Cohen D.M., Reinhardt R.A. Systemic sarcoidosis presenting with Horner's syndrome and mandibular paresthesia. Oral Surg Oral Med Oral Pathol. 1982;53:577–581. - PubMed
    1. Koczman J.J., Rouleau J., Gaunt M., Kardon R.H., Wall M., Lee A.G. Neuro-ophthalmic sarcoidosis: the University of Iowa experience. Semin Ophthalmol. 2008 May-Jun;23(3):157–168. doi: 10.1080/08820530802007382. PMID: 18432542. - DOI - PubMed
    1. Umur K.A., Tayfun B., Oguzhan O. Different ophthalmologic manifestations of sarcoidosis. Curr Opin Ophthalmol. 2012;23:477–484. - PubMed
    1. Wong J.C., Sparks J.A., Doyle T.J., et al. Systemic sarcoidosis presenting as harlequin and Horner's syndrome. Neurol Clin Pract. 2015;5:524–527. - PMC - PubMed
    1. Campagna G., Prospero Ponce C.M., Vickers A., et al. Neuro-Ophthalmic sarcoidosis. Neuroophthalmology. 2019 Feb 26;44(5):319–326. doi: 10.1080/01658107.2019.1583761. PMID: 33012922; PMCID: PMC7518323. - DOI - PMC - PubMed

Publication types

LinkOut - more resources